The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer. (Q51019962)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer. |
scientific article published in March 2004 |
Statements
The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer. (English)
1 reference
Peggy Manders
1 reference
Vivianne C G Tjan-Heijnen
1 reference
Paul N Span
1 reference
Nicolai Grebenchtchikov
1 reference
Anneke J Geurts-Moespot
1 reference
Doorléne T H van Tienoven
1 reference
Louk V A M Beex
1 reference
Fred C G J Sweep
1 reference
1 March 2004
1 reference
91
1 reference
3
1 reference
514-521
1 reference